Given the elevated Mcm10 levels [92,162,163,165,166] and frequency of genomic amplifications observed in cancer cells [168,169], it seems reasonable to propose that during oncogenesis cells rely on increased Mcm10 levels to ameliorate replication stress and drive cell cycle progression. The gene discussed is MCM10; the disease is cancer.